Torrent Pharmaceuticals quarterly results and financials

Torrent Pharmaceuticals (TORNTPHARM)₹4,780+0.15%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Torrent Pharmaceuticals reported sales of ₹4,983 Cr, up 50.8% from Sep 2025, and net profit of ₹536 Cr, down 9.6% year on year. For the year to Mar 2026, sales were ₹14,003 Cr and net profit ₹2,147 Cr.

Sales (Sep 2026): ₹4,983 Cr
Net profit (Sep 2026): ₹536 Cr
Sales (FY Mar 2026): ₹14,003 Cr
Net profit (FY Mar 2026): ₹2,147 Cr
EPS (Sep 2026): ₹14.10
Borrowings (Mar 2026): ₹14,987 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Torrent Pharmaceuticals quarterly results

₹ crore unless stated; each column is a quarter.

Torrent Pharmaceuticals Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	2,736	2,747	2,864	2,895	2,814	2,962	3,185	3,305	3,308	4,204	4,932	4,983
Expenses	1,863	1,861	1,954	1,951	1,896	1,995	2,148	2,220	2,214	2,843	3,255	3,313
Operating Profit	866	880	900	935	911	961	1,029	1,079	1,085	1,352	1,659	1,661
OPM %	32.0%	32.0%	32.0%	32.0%	33.0%	33.0%	32.0%	33.0%	33.0%	32.0%	34.0%	33.0%
Other Income	54.80	30.91	23.93	−15.94	32.91	−41.89	−36.85	−39.84	−22.92	−82.78	−32.87	−19.94
Interest	80.10	80.13	75.17	64.15	57.12	56.08	56.07	48.12	45.10	236	306	300
Depreciation	213	203	197	198	199	201	201	204	206	509	594	610
Profit before tax	633	632	658	663	692	667	740	793	816	530	735	739
Tax %	30.0%	29.1%	30.1%	31.1%	27.0%	25.1%	26.1%	25.1%	22.1%	31.1%	23.1%	28.1%
Exceptional items	61.89	0.00	0.00	0.00	0.00	−16.96	0.00	−8.98	−6.98	−44.95	−13.99	−5.99
Net Profit	444	450	458	454	505	500	550	593	637	365	568	536
EPS (Rs)	13.14	13.32	13.55	13.43	14.91	14.77	16.25	17.53	18.83	10.80	16.79	14.10

Torrent Pharmaceuticals profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Torrent Pharmaceuticals Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	6,693	5,822	5,961	7,685	7,957	8,020	8,527	9,636	10,736	11,526	14,003	17,427
Expenses	3,953	4,437	4,602	5,686	5,768	5,522	6,081	6,780	7,356	7,793	9,428	11,625
Operating Profit	2,725	1,373	1,345	1,977	2,164	2,471	2,424	2,831	3,356	3,710	4,543	5,756
OPM %	41.0%	24.0%	23.0%	26.0%	27.0%	31.0%	29.0%	30.0%	31.0%	32.0%	33.0%	33.0%
Other Income	31.89	222	298	−299	121	56.80	−287	44.86	146	−0.99	−182	−159
Interest	184	206	308	505	452	354	255	334	355	252	386	887
Depreciation	239	307	409	619	655	658	663	708	810	797	1,120	1,919
Profit before tax	2,350	1,091	933	563	1,191	1,530	1,229	1,852	2,357	2,680	2,880	2,821
Tax %	26.1%	14.1%	27.1%	22.0%	14.1%	18.0%	37.1%	33.1%	30.1%	28.1%	26.1%	—
Exceptional items	−101	53.94	41.91	−160	22.97	11.98	−298	27.97	74.84	−3.99	−27.97	−71.91
Net Profit	1,739	937	680	438	1,028	1,257	779	1,249	1,662	1,917	2,147	2,107
EPS (Rs)	51.44	27.71	20.13	12.94	30.38	37.15	23.07	36.95	49.12	56.69	64.17	60.52
Dividend payout %	34.1%	25.1%	35.1%	66.1%	53.1%	47.1%	105.1%	60.1%	57.1%	57.1%	59.1%	—

Torrent Pharmaceuticals balance sheet

₹ crore, at each year end.

Torrent Pharmaceuticals Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	84.91	84.82	84.85	84.89	84.96	84.90	84.87	84.92	169	169	169	169
Reserves	2,400	3,398	4,254	4,527	4,630	4,730	5,739	5,856	6,019	6,673	7,401	8,195
Borrowings	2,733	2,344	2,502	6,449	6,027	5,766	4,861	4,062	5,357	4,013	3,194	14,987
Other Liabilities	2,601	3,055	2,753	3,174	3,367	3,418	3,379	2,898	3,058	3,644	3,620	20,235
Total Liabilities	7,819	8,882	9,594	14,234	14,108	13,999	14,064	12,899	14,603	14,499	14,385	43,586
Fixed Assets	2,829	2,854	3,682	7,844	7,739	7,517	7,056	6,415	8,112	8,131	7,936	33,162
CWIP	677	1,040	518	645	615	711	888	629	764	360	477	640
Investments	298	779	803	491	352	1.99	181	226	199	173	156	948
Other Assets	4,015	4,209	4,591	5,253	5,401	5,769	5,939	5,631	5,527	5,836	5,817	8,835
Inventories	1,069	1,359	1,560	1,968	1,938	2,152	2,684	2,465	2,232	2,282	2,542	3,143
Trade receivables	1,587	1,446	951	1,254	1,436	1,648	1,524	1,632	1,943	1,845	1,866	3,032
Cash & equivalents	566	646	892	865	813	665	603	402	569	836	578	1,163
Total Assets	7,819	8,882	9,594	14,234	14,108	13,999	14,064	12,899	14,603	14,499	14,385	43,586

Torrent Pharmaceuticals cash flow

₹ crore, for each year.

Torrent Pharmaceuticals Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	808	2,733	1,006	891	1,793	1,389	1,998	1,799	2,363	3,258	2,578	3,016
Cash from investing activity	−2,114	−869	−799	−4,681	−246	229	−445	−196	−2,337	−160	−549	−12,644
Cash from financing activity	1,214	−1,437	−193	3,418	−1,315	−1,551	−1,653	−1,784	77.04	−2,782	−2,302	10,170
Net cash flow	−89.72	435	17.93	−365	237	72.76	−88.70	−173	110	326	−261	542
Capex	243	599	487	791	663	407	335	203	575	433	612	677
Free cash flow	576	2,157	525	105	1,142	993	1,676	1,612	1,960	2,977	1,998	2,394
CFO / OP %	84.9%	121.0%	100.9%	87.0%	104.9%	76.9%	88.0%	91.0%	97.0%	112.0%	85.9%	84.0%

Torrent Pharmaceuticals ratios

Working-capital days and returns, by year.

Torrent Pharmaceuticals Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	126	80	61	78	69	77	70	71	75	64	60	80
Inventory days	274	313	317	428	317	361	455	367	297	309	333	337
Days payable	472	523	356	447	345	345	351	250	224	284	239	254
Cash conversion cycle	−70	−129	22	60	43	94	175	189	148	90	155	164
Working capital days	29	−1	28	−80	−62	−52	−5	7	−33	−27	7	−26
ROCE %	27.0%	48.1%	19.0%	13.0%	13.0%	15.1%	17.0%	19.0%	20.0%	23.0%	27.0%	15.0%

Torrent Pharmaceuticals: frequently asked questions

What are the latest quarterly results of Torrent Pharmaceuticals?

For the Sep 2026 quarter, Torrent Pharmaceuticals reported sales of ₹4,983 Cr, up 50.8% year on year and net profit of ₹536 Cr, down 9.6% year on year. The operating margin was 33.0%.

What is the annual revenue of Torrent Pharmaceuticals?

Torrent Pharmaceuticals' sales for the year to Mar 2026 were ₹14,003 Cr; over the last twelve months they were ₹17,427 Cr.

What is the net profit of Torrent Pharmaceuticals?

Net profit for the year to Mar 2026 was ₹2,147 Cr, and ₹2,107 Cr over the last twelve months. Earnings per share over the same trailing period were ₹60.52.

How much debt does Torrent Pharmaceuticals have?

Torrent Pharmaceuticals reported borrowings of ₹14,987 Cr at Mar 2026, against cash and equivalents of ₹1,163 Cr.

What is the free cash flow of Torrent Pharmaceuticals?

Cash from operations was ₹3,016 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹2,394 Cr.

Loading…